Skip to content

Moderna Shares Extend Sharp Rise to Sit Near 52-Week High

Moderna shares are up more than 5% in a US session that is still running, following a sharp gain yesterday and leaving the stock close to its 52-week high after a very large gain this year.

Moderna (NASDAQ: MRNA), the biotechnology company, was trading at $239.68 by 1.38pm in New York today, up 5.5% on the day. The US session is still running. The shares have traded between $216.65 and $240.16 so far, with the high only just above the latest level.

The level sits 1.4% below the stock’s 52-week high and 972.5% above its 52-week low. Moderna is up 713.2% so far this year.

Line chart of Moderna daily share price over the past month, plus today's session so far
Moderna’s daily closing share price over the past month, plus today’s session so far.

How unusual this is

Moderna also rose sharply yesterday, so the stock is heading for a second big gain in a row if the move holds into the close. Today’s move so far ranks 28th among the last 126 sessions.

MRNA.US

In the news

Yahoo Finance reported on Monday that Moderna was among several stocks to jump in the afternoon session, as investors rotated into defensive assets and priced in rising expectations that midterm election outcomes could reverse recent federal spending cuts.

Moderna’s next results are due on Friday the 6th of November.

Asktraders News Team
Asktraders News Team
Team Member

The AskTraders Analyst Team features experts in technical and fundamental analysis, as well as traders specializing in stocks, forex, and cryptocurrency.

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.